Prime Biosciences PC announces that has entered into an exclusive distribution agreement with Calmark Sweden AB (publ) for their innovative Neo Platform.
Calmark was founded in 2007 and has focused on newborn care ever since. The company's existing solution is based on thirteen years of research and experience in the industry. Calmark's activities are focused on improving the entire chain of care, with the aim of reducing patients' suffering, saving on care costs and time.
With Calmark's POC-Analyzer Neo and the Neo-Bilirubin test cassettes, Prime Biosciences aims to make the measurement of bilirubin accessible to every corner of Greece in an easy, quick and cost effective way.